concept

DOPAMINERGIC

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DOPAMINERGIC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1443Connections
3Hypotheses
0Analyses
50Outgoing
50Incoming
8Experiments
0Debates

Summary

DOPAMINERGIC is a concept in neurodegeneration research. Key relationships include: co discussed, causes, regulates. Associated with NEURODEGENERATION, PARKINSON, PARKINSON'S. Connected to 145 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameDOPAMINERGIC
Key Genes/ProteinsACHE, ACTB, AD, AIF1, AKT, Alpha-Synuclein
Related Diseasesaging, Alzheimer'S Disease

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Continuous Dopaminergic Stimulation for Parkinson's Disease

company · 523 words

Pathway Diagram

graph TD
    DOPAMINERGIC["DOPAMINERGIC"]
    DOPAMINERGIC -->|"causes"| NEURON["NEURON"]
    DOPAMINERGIC -->|"causes"| NEURONS["NEURONS"]
    DOPAMINERGIC -->|"causes"| SENESCENCE["SENESCENCE"]
    DOPAMINERGIC -->|"causes"| PARKIN["PARKIN"]
    DOPAMINERGIC -->|"causes"| PARKINSON["PARKINSON"]
    DOPAMINERGIC -->|"causes"| PARKINSON_S["PARKINSON'S"]
    DOPAMINERGIC -->|"causes"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    DOPAMINERGIC -->|"causes"| SUBSTANTIA_NIGRA["SUBSTANTIA NIGRA"]
    DOPAMINERGIC -->|"regulates"| PI3K["PI3K"]
    AKT["AKT"] -->|"regulates"| DOPAMINERGIC
    ASTROCYTE["ASTROCYTE"] -->|"interacts"| DOPAMINERGIC
    ASTROCYTES["ASTROCYTES"] -->|"interacts"| DOPAMINERGIC
    COMPLEMENT["COMPLEMENT"] -->|"activates"| DOPAMINERGIC
    APOPTOSIS["APOPTOSIS"] -->|"causes"| DOPAMINERGIC
    AMPK["AMPK"] -->|"activates"| DOPAMINERGIC
    AUTOPHAGY["AUTOPHAGY"] -->|"promotes"| DOPAMINERGIC

Outgoing (538)

TargetRelationTypeStr
MICROGLIAexpressescell_type0.70
LRRK2associated_withgene0.70
JAKinhibitsgene0.70
NEURONSenhancescell_type0.70
WNTactivatesgene0.70

Incoming (905)

SourceRelationTypeStr
ATP13A2associated_withgene0.70
CHRNA7regulatesgene0.70
BDNFexpressesgene0.70
ATG5mediatesgene0.70
ACHEregulatesgene0.70

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A 0.790 neurodegeneration epigenetic reprogramming aging neurons
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio 0.740 neuroscience Circuit-level neural dynamics in neurode
Correcting Gut Microbial Dopamine Imbalance to Support Syste 0.606 neurodegeneration What are the mechanisms by which gut mic

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (8)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Plasma ATN biomarkers across AD continuum in Chilean cohort clinical Alzheimer's disease 0.950 0.00 Chilean older adults (n=318) w proposed N/A
Tau depletion effects on neuronal development in primary cultures exploratory 0.900 0.00 primary rodent neuronal cultur proposed N/A
Differential GWAS of schizophrenia vs PTSD exploratory schizophrenia, post-traumatic 0.900 0.00 human patients - European ance proposed N/A
Tau depletion effects on neuronal development in primary cultures exploratory 0.900 0.00 primary rodent neuronal cultur proposed N/A
Creation and validation of 3xAD-ChAT-Cre mouse model validation Alzheimer's disease 0.900 0.00 3xAD-ChAT-Cre transgenic mice proposed N/A
GTEx brain tissue expression analysis of MAPT/CRHR1 locus exploratory schizophrenia, post-traumatic 0.850 0.00 human brain tissue samples fro proposed N/A
Microtubule domain analysis in adult axons exploratory 0.800 0.00 adult rodent axons proposed N/A
Tau depletion effects on microtubule domains in adult axons exploratory 0.800 0.00 adult rodent neurons proposed N/A

Related Papers (8)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders [PMID:41699128] ["Bolsewig K", "Bellomo G", "Hok-A-Hin Y Nature medicine 2026 0
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by [PMID:39881147] ["Bolsewig K", "Willemse E", "S\u00e1nch Nature communications 2025 0
Characterization of Vps13b-mutant mice reveals neuroanatomical and behavioral ph [PMID:37573958] ["Montillot C", "Skutunova E", "Ayushma" Neurobiology of disease 2023 0
Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neu [PMID:36692274] ["Motta C", "Assogna M", "Bonomi C", "Di European journal of neurology 2023 0
Bi-allelic loss of function variants in SLC30A5 as cause of perinatal lethal car [PMID:33547425] Lieberwirth JK, Joset P, Heinze A, Hents European journal of human gene 2021 0
Environmental Regulation, Technological Innovation, and Export Competitiveness: [PMID:32102174] Liu J, Xie J International journal of envir 2020 0
Predicting Subjective Recovery from Lower Limb Surgery Using Consumer Wearables. [PMID:33442582] Karas M, Marinsek N, Goldhahn J, Foschin Digital biomarkers 2020 0
DOPA Decarboxylase Modulates Tau Toxicity. [PMID:28751068] ["Kow R", "Sikkema C", "Wheeler J", "Wil Biological psychiatry 2018 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity